LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT)

Disseminated on behalf of Nevada Organic Phosphate Inc., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT).

LIXTE is developing a first-in-class therapy designed to enhance the effectiveness of existing cancer treatments

Its lead compound, LB-100, targets PP2A and is advancing through multiple clinical trials with a favorable safety profile

The company is building a differentiated oncology pipeline supported by experienced leadership and scientific expertise

LIXTE Biotechnology (NASDAQ: LIXT) is a clinical-stage pharmaceutical company leading efforts in addressing some of the pressing challenges in cancer treatment. Instead of developing standalone cancer drugs, the company is adopting a different strategy aimed at enhancing the overall effectiveness of existing immunotherapy and chemotherapy regimens through a novel biological target.

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) is a clinical-stage pharmaceutical company developing differentiated cancer therapies built around a novel biological target. Rather than introducing standalone treatments, the company is focused on advancing a first-in-class approach designed to enhance the effectiveness of established cancer therapies, addressing persistent challenges that continue to limit outcomes in oncology.

LIXTE’s work centers on improving how chemotherapy and immunotherapy perform in difficult-to-treat cancers with significant unmet medical need. By translating a distinct scientific concept into therapies that can be integrated into existing treatment frameworks, the company aims to expand the reach and impact of current standards of care without requiring wholesale changes to clinical practice.

Alongside internal development, LIXTE has pursued selective strategic actions that extend its capabilities beyond drug development, supporting its evolution into a platform-oriented oncology company spanning both pharmaceutical and technology-driven approaches.

The company is headquartered in Boca Raton, Florida.

Portfolio

LB-100 (PP2A Inhibitor Platform)

LIXTE’s lead clinical candidate, LB-100, is a proprietary small-molecule inhibitor of protein phosphatase 2A (PP2A) designed to enhance the activity of chemotherapy and immunotherapy. The compound has demonstrated a favorable safety profile in Phase 1 clinical trials and has been supported by more than 25 published preclinical and translational studies. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with limited treatment options.

Ongoing trials include combinations of LB-100 with immunotherapy in ovarian clear cell carcinoma and metastatic MSI-low colon cancer, as well as combination therapy with chemotherapy in advanced soft tissue sarcoma. These studies are being conducted in collaboration with leading academic cancer centers and industry partners, reflecting LIXTE’s emphasis on externally validated clinical execution.

Radiotherapy Platform Expansion (Liora Technologies)

In November 2025, LIXTE expanded beyond pharmaceuticals with the acquisition of Liora Technologies Europe Ltd., adding an electronically controlled proton therapy platform known as the LiGHT System. This acquisition established LIXTE’s entry into radiotherapy, complementing its drug development activities and creating optionality for future recurring revenue models tied to jointly operated treatment centers.

Market Opportunity

LIXTE is targeting cancers where existing therapies show limited durability due to resistance, toxicity constraints, or suboptimal patient response. Chemotherapy and immunotherapy are widely applicable across tumor types but remain constrained by these factors, creating an opportunity for approaches that improve efficacy without proportionally increasing toxicity.

The company’s clinical programs focus on ovarian clear cell carcinoma, metastatic colon cancer, and advanced soft tissue sarcoma, indications characterized by high unmet need and limited effective treatment options. Rather than reshaping oncology care, LIXTE is developing LB-100 to augment existing therapies, an approach that could support wider clinical use within established treatment pathways.

Leadership Team

Geordan Pursglove, Chairman, President and Chief Executive Officer, is an accomplished executive and entrepreneur with more than a decade of experience spanning mergers and acquisitions, capital markets, strategic growth initiatives, and operational leadership across both public and private companies. His background includes leadership roles across technology, logistics, customer experience, sports, and marketing, with a focus on scaling organizations, raising capital, and executing transformative strategies.

Bas van der Baan, Chief Scientific Officer, has more than 20 years of experience in biotechnology with a concentration in oncology and diagnostics. He previously served as Chief Clinical and Business Development Officer at Agendia, where he played a key role in initiating and executing clinical trials that supported the commercialization of precision molecular oncology diagnostics in both the U.S. and Europe.

Peter Stazzone, Chief Financial Officer, brings over two decades of financial management experience across publicly traded and privately held companies. His background includes leading capital raises, mergers and acquisitions, financial controls, and public company reporting, with prior CFO roles at companies including Beyond Commerce, Strainz, and Voice Telecom.

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), closed Thursday's trading session at $3.35, up 6.0127%, on 29,330 volume. The average volume for the last 3 months is 86,607 and the stock's 52-week low/high is $0.64/$6.26.

Recent News

• LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) - LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy
• BioMedNewsBreaks - LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit at Morehouse College
• InvestorNewsBreaks - Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) to Participate In DealFlow Discovery Conference

Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)

The QualityStocks Daily Newsletter would like to spotlight Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG).

Hong Kong is placing increased strategic emphasis on the gold market as part of its broader ambition to enhance its position in the global commodities landscape. The Special Administrative Region is fast-tracking initiatives to establish itself as a leading international center for gold trading. By capitalizing on its strong cross-border connectivity, advanced infrastructure, and sophisticated financial services sector, the city aims to offer investors a wider range of opportunities while strengthening its competitive advantage. Christopher Hui Ching-yu, the Secretary for Financial Services and the Treasury, outlines why these initiatives are being rolled out at this moment and how the city plans to convert its advantages into a comprehensive gold market. When asked about the next steps, Hui discussed the priorities they had to bring the plan to fruition. First, Hong Kong will establish a government-backed clearing system, in addition to setting up an industry association to gather broad input from stakeholders across the entire value chain, ensuring policy decisions are informed by market perspectives. Additionally, he revealed that the city aims to build a comprehensive product ecosystem by expanding beyond physical gold storage to include financial instruments such as exchange-traded funds and futures. The planned creation of a gold trading hub in Hong Kong is a development that mining companies like Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) are likely to take an interest in since it could introduce new market dynamics that could reshape how gold is traded globally. 

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (PGM) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanised platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.

The project is a joint venture between Platinum Group; integrated PGM producer Impala Platinum Holdings Ltd. (OTCQX: IMPUY); Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security (JOGMEC); and local empowerment partner Mnombo Wethu Consultants (Pty) Ltd. Platinum Group has an effective 50.22% interest in the Waterberg Project.

The company’s primary business objective is to advance the Waterberg Project to a development and construction decision. An update to the 2019 Definite Feasibility Study is expected in 2024.

PGMs are essential and precious metals that include platinum, palladium, rhodium, iridium, osmium and ruthenium. These metals are known for their purity, high melting points and unique catalytic properties. They are utilized in a number of industrial processes, technologies and commercial applications and play a critical role in autocatalysis and pollution control in the automotive sector. The bulk of global PGMs are mined in Southern Africa and Russia.

The unique properties of PGMs are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The company’s battery technology initiative through Lion Battery Technologies Inc., using platinum and palladium in lithium battery technologies, represents one such new opportunity in the high-profile lithium battery research and innovation field.

Platinum Group Metals Ltd. founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JNB) to support the use of palladium and platinum in lithium battery applications. Lion Battery has entered into an agreement with Florida International University to further advance a research program that uses platinum and palladium to unlock the potential of Lithium Sulfur (Li-S) battery chemistries.

Platinum Group is headquartered in Vancouver, B.C., and Johannesburg, South Africa.

Waterberg Project

Platinum Group’s sole material mineral property, the Waterberg Project, is presently in process with pre-construction permitting; engineering work, including road upgrade and traffic studies; finalization of power and water infrastructure design; and construction camp design.

The company’s principal product from the Waterberg Project is planned to be a PGM-bearing concentrate. The concentrate will contain economic amounts of six elements comprising platinum, palladium, rhodium, gold, copper and nickel. The company’s partner in the Waterberg Project, Impala Platinum Holdings, has acquired a right of first refusal to enter into an offtake agreement, on commercial arm’s-length terms, for the smelting and refining of mineral products from the Waterberg Project.

The Waterberg project has proven and estimated reserves of 19.5 million ounces of PGMs and gold. When fully operational, the mine is projected to produce more than 400,000 ounces of PGMs annually during the peak period of steady state production. The life of the mine is projected at 45 years.

South Africa’s PGM mining sector remains closely tied to economic developments in the global automotive industry, which in 2022 accounted for approximately 43% of the total global demand for platinum and 82% of the total global demand for palladium.

Market Opportunity

According to a report from Straits Research, a global market and business research firm, the worldwide platinum market had an estimated value of $7.72 billion in 2022 and is projected to reach $11.95 billion by 2031. That represents a CAGR of 5.13% over the forecast period.

Platinum, one of the rarest of precious metals, is about 30 times scarcer than gold. It is crucial to the automotive and electronics industries and is also used to make jewelry. Stricter emissions regulations around the world have led to an increased demand for platinum to be used in catalytic converters to reduce automotive emission, the report states.

A report from Allied Market Research estimated the global palladium market at $16.3 billion in 2021 and projects the market will reach $28.6 billion by 2031, growing at a CAGR of 5.8% over the period.

Palladium is also used in automotive catalytic converters for reducing emissions and in jewelry, dentistry, watchmaking, blood sugar test strips, aircraft spark plugs, surgical instruments, electrical contacts and musical instruments.

An increase in demand for consumer electronics has driven demand for palladium-based multilayer ceramic capacitors (MLCC) used to store energy in electronic devices such as broadcasting equipment, mobile telephones, computers, electronic lighting and high voltage circuits, according to the report.

Management Team

Frank R. Hallam is Co-Founder, Director, President and CEO of Platinum Group. He has over 30 years of experience in the mining, minerals and petroleum industry as an operator, principal and founder. He was a co-founder and former CFO of MAG Silver Corp. He was also co-founder and director of West Timmins Mining Inc. and a director of Lake Shore Gold Corp. In addition, he was CFO and director with gold exploration company Tan Range Exploration Corp. He is a Chartered Professional Accountant and was formerly an auditor in the public mining practice of PwC. He holds a Bachelor of Business Administration from Simon Fraser University.

Greg Blair is CFO of Platinum Group. He has been with Platinum Group since 2010 in various roles, most recently as Interim CFO. Prior to joining Platinum Group, he was at a public accounting firm working on public company (mainly mining) audits. He is a Chartered Professional Accountant and holds a degree in Economics from Simon Fraser University and has completed the Canadian Securities Course.

Kris Begic is VP Corporate Development of Platinum Group. He has over 25 years of experience in the mining industry and capital markets and has been involved with the raising of over $500 million for various exploration and development projects globally. His efforts are focused on project generation, mergers and acquisitions, capital markets, investor relations and marketing.

Platinum Group Metals Ltd. (NYSE American: PLG), closed Thursday's trading session at $2.92, up 10.6061%, on 8,168,998 volume. The average volume for the last 3 months is 4,650,390 and the stock's 52-week low/high is $0.99/$3.36.

Recent News

• Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) - Hong Kong Seeks to Become Gold Trading Hub
• Platinum and Palladium Face an Inflection Point in 2026
• Analysts Say $210bn Investment is Needed to Boost Copper Mining

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT).

HeartBeam (NASDAQ: BEAT) , a medical technology company focused on advancing cardiac care through actionable cardiac insights, announced the appointment of Bryan Humbarger as chief commercial officer, effective Jan. 22, 2026. In the newly created role, Humbarger will lead commercial strategy and execution across key growth initiatives, including the limited launch of the recently cleared HeartBeam System for arrhythmia assessment, heart attack detection indication and a 12-lead ECG extended wear patch monitor, while expanding outreach to cardiology partners to validate real-world performance and establish reference sites for broader adoption.

To view the full press release, visit https://ibn.fm/9YzeT

HeartBeam Inc. (NASDAQ: BEAT) is a medical technology company pioneering a new approach to cardiac care by delivering hospital-grade electrocardiogram (ECG) insights outside traditional clinical settings. Its proprietary platform supports a scalable app-based solution for real-time heart monitoring.

The company’s mission is to empower both patients and physicians with actionable cardiac data wherever symptoms begin, addressing a critical gap in the first hours of cardiac events. Through its connected cardiac care ecosystem, HeartBeam is establishing a new model for remote monitoring that deepens patient engagement and delivers more actionable insights for physicians. This approach is designed to obtain early diagnosis which could reduce time to treatment, improve outcomes, and lower costs across the healthcare continuum.

HeartBeam’s system aims to bring clinical-grade cardiac assessment into the home. HeartBeam is preparing for commercial launch as its 12-lead ECG synthesis software undergoes regulatory review, building on prior clearance of its 3D ECG system for arrhythmia assessment. The company plans to leverage its unique longitudinal ECG dataset and deep learning algorithms to advance predictive capabilities in the future.

HeartBeam is headquartered in Santa Clara, California.

Products

HeartBeam’s flagship innovation is its credit card-sized, cable-free ECG device that collects heart signals in three non-coplanar dimensions and synthesizes a 12-lead ECG. Cleared by the FDA in December 2024 for arrhythmia assessment, the HeartBeam System enables patients to capture high-fidelity heart data during symptomatic episodes, even outside a clinical environment.

The company’s pending 12-lead ECG synthesis software, developed from the same 3D signal acquisition, successfully met clinical endpoints in the VALID-ECG study and is currently under FDA review for arrhythmia assessment. This software combined with an on-demand cardiologist reader service is expected to form the backbone of HeartBeam’s commercial launch strategy, providing patients with access to a synthesized 12-lead ECG outside of the traditional hospital setting and enabling physician interpretation of patient ECGs from anywhere.

From the core, the team is building an ecosystem that includes integration with wearables, automated arrhythmia assessments, AI-driven wellness features, community features and trending insights. The ecosystem is intended to drive adoption and increase the overall value of the HeartBeam System.

Artificial Intelligence and Predictive Analytics

To enhance its diagnostic capabilities, HeartBeam is developing AI-powered arrhythmia detection algorithms to be validated in collaboration with Mount Sinai Heart. In early testing, these deep learning algorithms achieved diagnostic accuracy comparable to standard 12-lead ECGs when classifying atrial fibrillation, atrial flutter, and sinus rhythm.

Additionally, HeartBeam’s AI engine has the potential to transform routine monitoring into predictive power in the future. The company’s platform enables frequent readings, building a unique longitudinal ECG dataset unique that no one else offers. By leveraging deep learning on the repeated measurements, there is an opportunity to develop predictive capabilities, such as screening for hidden cardiac conditions and forecasting risk of future events. The unique longitudinal dataset will create a defensible data moat as the company continues to advance its AI program.

Market Opportunity

HeartBeam is targeting a large unmet need in cardiac care by delivering hospital-grade ECG diagnostics to patients outside of traditional healthcare settings. Cardiovascular disease is the leading cause of death worldwide, yet most cardiac events occur at home, where standard 12-lead ECGs are not available, leading to costly delays in diagnosis and treatment. HeartBeam’s FDA-cleared 3D ECG technology is designed to close this critical gap with on-demand, remote diagnostic capabilities.

The company’s initial commercialization strategy focuses on two distinct U.S. entry markets. The first includes approximately 500,000 elevated-risk patients in concierge care settings, representing a $250 million to $500 million annual revenue opportunity. The second addresses a larger direct-pay segment of 2.6 million elevated-risk individuals, with potential revenues of $1.3 billion to $2.6 billion annually. Future expansion may include reimbursement-driven pathways through Medicare Advantage, providers, and payer partnerships.

HeartBeam anticipates annual subscription pricing between $500 and $1,000 per patient, with roughly 50% gross margins on device costs and 70%+ on recurring revenue. Based on a model using five U.S. regions, each with an estimated 75,000 eligible patients, HeartBeam projects that just 10% adoption would generate approximately $20 million in gross profit—enough to reach cash flow break-even under current pricing and margin assumptions. Over time, the company’s longitudinal ECG dataset and predictive AI capabilities are expected to deliver additional value to healthcare systems, research institutions, and life science partners.

Leadership Team

Robert Eno, Chief Executive Officer and Director, brings over 30 years of experience in the medical technology industry, including leadership roles at HeartFlow, OptiMedica, and NeoGuide Systems. He joined HeartBeam as President in January 2023 and was appointed CEO in October 2024, later joining the board in May 2025 to support commercial growth.

Branislav Vajdic, Ph.D., Founder and Chief Technology Officer, is a semiconductor and medtech innovator who previously led product design teams at Intel and founded NewCardio. He holds over 20 patents and is the original architect of HeartBeam’s core technology.

Tim Cruickshank, Chief Financial Officer, oversees financial strategy and capital allocation. He works closely with the leadership team to support commercialization while maintaining financial discipline aligned with key regulatory milestones.

Peter Fitzgerald, M.D., Ph.D., Chief Medical Advisor, is Director of the Center for Cardiovascular Technology at Stanford and a seasoned clinical trialist with over 175 studies and 650 publications. He has founded over 20 medtech companies and advises the FDA on digital health analytics.

Ken Persen, Chief Technology Officer, has more than 28 years of experience in cardiac rhythm management and digital health. He previously served as CTO and CEO at LIVMOR and held engineering roles at Cameron Health and Guidant.

HeartBeam Inc. (NASDAQ: BEAT), closed Thursday's trading session at $1.87, up 0.5376344%, on 1,186,078 volume. The average volume for the last 3 months is 5,562,197 and the stock's 52-week low/high is $0.54/$4.

Recent News

• HeartBeam Inc. (NASDAQ: BEAT) - BioMedNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer 
• BioMedNewsBreaks - FDA Clearance for HeartBeam Inc. (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup
• NetworkNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference

ParaZero Technologies Ltd. (NASDAQ: PRZO)

The QualityStocks Daily Newsletter would like to spotlight ParaZero Technologies Ltd. (NASDAQ: PRZO).

ParaZero Technologies (NASDAQ: PRZO) , an aerospace defense company advancing smart, autonomous solutions for the global manned and unmanned aerial systems market, highlighted key industry trends and company milestones from 2025 that advanced its DefendAir counter-UAS platform, as global drone threats intensified across military, urban security and critical infrastructure environments. The Company cited strong growth in the counter-UAS market driven by increased use of low-cost commercial drones, rising global defense spending and demand for layered, modular and non-explosive solutions, particularly in urban settings, while noting DefendAir's progress as a multi-layered, net-based interception platform that achieved a 100% success rate in controlled trials and reinforced ParaZero's strategic positioning amid accelerating worldwide adoption of precision drone interception technologies.

To view the full press release, visit https://ibn.fm/bm4uL

ParaZero Technologies Ltd. (NASDAQ: PRZO) is a defense aerospace company specializing in multi-layered Counter-Unmanned Aircraft System (“Counter-UAS”) technologies engineered to neutralize hostile drones in complex, contested, and urban environments. Founded by aviation and defense technology professionals, the company develops autonomous interception and precision-delivery systems that support military forces, homeland security agencies, and operators of strategic infrastructure. ParaZero’s mission is to provide reliable, practical, and scalable counter-drone capabilities for frontline and fixed-site defense scenarios where rapid, accurate, and low-collateral response is essential.

As drone threats evolve from low-cost commercial platforms to fast, low-signature systems operating in RF-denied conditions, ParaZero focuses on solutions that deliver actionable last-layer defense. Its technologies integrate with existing detection and command systems, allowing operators to respond effectively across military bases, sensitive facilities, border regions, and high-risk operational zones. The company’s defense portfolio continues to expand through field collaboration with Israeli defense authorities and international security organizations seeking capable interception systems.

Building on more than a decade of engineering and operational experience, ParaZero offers autonomous counter-drone and precision-delivery capabilities designed for modern defense requirements.

The company is headquartered in Kfar Saba, Israel.

DefendAir

DefendAir is ParaZero’s multi-layered Counter-UAS system designed to intercept hostile drones with high accuracy and minimal collateral damage. The platform employs patented net-interception technology and supports defense forces protecting bases, critical infrastructure, government facilities, and frontline units. Company-reported demonstrations conducted with Israeli defense and homeland security authorities have shown successful interception across a range of real-time scenarios involving fast, maneuverable, and RF-denied drones.

DefendAir is deployed through three complementary delivery mechanisms that enable flexible interception across dynamic battlefield and fixed-site environments:

• Interception Drone – The airborne configuration places a net-interception pod on an autonomous multirotor, enabling rapid engagement of hostile drones approaching from extended ranges or complex angles. This mobile layer offers adaptable response options where ground-based systems may have limited reach.
• Stationary Turret – The turret provides automated 360-degree perimeter coverage for fixed sites. Using optical detection and autonomous tracking, it identifies and intercepts approaching drones with a non-explosive, low-collateral method suitable for urban or sensitive environments.
• Hand-Held Net Launcher – The hand-held launcher offers infantry and security personnel a lightweight, tactical close-range interception tool. It enables unit-level drone neutralization in environments where jamming or spoofing is ineffective, providing a practical last-line defense option.

Together, these configurations provide flexible interception capabilities for a wide range of defense and security missions.

DropAir

DropAir is ParaZero’s high-accuracy aerial delivery solution engineered for autonomous or remotely controlled missions in complex and hostile environments. The system enables safe, precise delivery of sensitive payloads, including medical supplies, blood transfusions, tactical equipment, and humanitarian aid, without requiring the drone to land or expose ground personnel to risk. Its HALO-style late parachute deployment minimizes drift and lowers detectability, supporting both multirotor and fixed-wing UAVs.

DropAir has demonstrated operational effectiveness in collaboration with the Israeli Ministry of Defense and the Israel Defense Force Medical Corps, including a breakthrough field trial in which blood transfusions dropped from 200 meters were recovered fully intact and suitable for human use.

The system’s modular pod design secures a variety of payloads and is adaptable to a wide range of UAV platforms, with carrying capacities of 5, 10, or 20 kilograms depending on drone capability. Built for rapid deployment and all-weather performance, DropAir provides reliable resupply options for defense, disaster response, and remote operations where conventional logistics cannot safely reach.

Market Opportunity

ParaZero operates within rapidly expanding segments of the global unmanned systems and defense markets. According to Fortune Business Insights, the anti-drone (counter-UAS) market was valued at $2.4 billion in 2024 and is projected to grow from $3.1 billion in 2025 to $12.24 billion by 2032, reflecting a compound annual growth rate of 21.62%. This expansion is driven by the increasing use of drones in modern conflicts, the emergence of new threat types such as RF-denied and fiber-optic-guided drones, and the need to protect critical infrastructure, military bases, and sensitive facilities.

The precision airdrop category is also gaining traction as defense forces and emergency agencies seek secure, rapid, and unmanned delivery solutions for time-critical missions. ParaZero’s DropAir program has advanced into Phase II with the Israeli Defense Force Medical Corps, highlighting governmental adoption of autonomous delivery technologies for military and humanitarian use.

Leadership Team

Ariel Alon, Chief Executive Officer, is an experienced executive with a proven track record of leading high-performing business teams across unmanned aircraft systems, finance, high-tech, defense, and government sectors in Israel, the U.S., EMEA, and APAC. Prior to joining ParaZero, he served as Chief Sales Officer of Aerodrome Group and CEO of its subsidiary, Aerodrome LTD. His earlier roles include vice president of sales and general manager for Israel at Voyager Labs, Israeli country manager for Atos, and business development positions at companies including Elbit Systems and Rafael Advanced Defense Systems. Mr. Alon holds a B.A. in business administration and an M.B.A. in finance and marketing from the Ruppin Academic Center in Israel.

Regev Livne, Chief Financial Officer, previously served as CFO of Votiro, where he raised capital and supported the company’s expansion into North America and Asia. His earlier experience includes serving as CFO of SCR Engineers Ltd., along with finance roles at 3M Attenti and Dmatek Ltd. Mr. Livne began his career as a senior accountant at PwC Israel, auditing both public and private companies. He is a Certified Public Accountant in Israel and holds a master’s degree in finance and management and a B.A. in business administration and accounting from the Israeli College of Management.

Alon Yasovsky, Vice President of R&D, is an engineering leader with more than 20 years of experience across electro-optics, machine vision, embedded systems, and advanced technology development. He previously worked in Samsung Electronics Israel’s Open Innovation group and evaluated R&D investments for the Israeli Innovation Authority. Earlier in his career, he held engineering and leadership roles at SensoGenic, Kornit Digital, Intel, Apple, PrimeSense, and Elbit Systems. Mr. Yasovsky holds a B.Sc. in electrical and electronic engineering from Tel Aviv University and completed the U.S.–Israel Innovation Bridge Leadership Executives Program at the University of California, Irvine.

Paid Promotional Disclosure

This press release constitutes a paid promotional communication. The Company has engaged a third-party service provider to provide investor awareness and promotional services, including the dissemination of this press release, and has paid a fee for such services. The Company exercises editorial control over the content of this press release but does not control how, when, or to whom the information is distributed by such third party.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company. Investing in securities involves significant risks, and readers are encouraged to review the Company’s filings with the U.S. Securities and Exchange Commission available at www.sec.gov before making any investment decision.

ParaZero Technologies Ltd. (NASDAQ: PRZO), closed Thursday's trading session at $1.33, up 11.7647%, on 1,157,531 volume. The average volume for the last 3 months is 2,275,770 and the stock's 52-week low/high is $0.5255/$2.145.

Recent News

• ParaZero Technologies Ltd. (NASDAQ: PRZO) - TinyGemsBreaks - ParaZero Technologies Ltd. (NASDAQ: PRZO) Highlights 2025 Advancements Driving DefendAir Counter-UAS Momentum
• DefenseNewsBreaks - ParaZero Technologies Ltd. (NASDAQ: PRZO) Signs Reseller Agreement for Cyprus Homeland Security Market
• TechMediaBreaks - ParaZero Technologies Ltd. (NASDAQ: PRZO) Engages IBN to Expand Investor and Corporate Communications Reach

ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF)

Disseminated on behalf of ShelfieTech Ltd., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF).

Disseminated on behalf of ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) and may include paid advertising.

ShelfieTech (CSE: SHLF) (OTCQB: SHLFF) recently outlined a series of accomplishments in 2025 that reflect both strategic execution and momentum in deploying its next-generation retail automation technology. "From financing success to dual exchange listings and product development advancements, the company's update highlights a year of meaningful corporate progress," reads a recent article. "In terms of product development, ShelfieTech has reached a foundational milestone by concluding the first stage of research and development for its Robotic Retail Shelf Monitoring System. This robotic platform, designed to automate the capture of shelf-level data and enable more accurate, real-time visibility of in-store conditions, marks a key innovation in the company's technology roadmap. With this stage complete, ShelfieTech plans to begin beta installations in supermarket environments, a crucial step that will allow the company to validate system performance in real-world settings and collect operational data ahead of broader commercial rollout."

To view the full article, visit https://nnw.fm/DmOFP

ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) is a technology company dedicated to transforming retail inventory management through automation and modern engineering. The company’s vision centers on simplifying the future of retail by reducing the friction between people, shelves and data, enabling retailers to operate with greater reliability and responsiveness. Its mission is to create technology that elevates store performance while supporting employees with tools that remove unnecessary manual tasks.

Built on values of consideration, collaboration and efficiency, ShelfieTech focuses on solutions that enhance both operational flow and the human–technology relationship. The company emphasizes user-friendly design and thoughtful automation, ensuring that store teams are empowered rather than replaced. This value-driven approach guides every product and workflow the company develops.

Through this philosophy, ShelfieTech aims to help retailers deliver consistently stocked shelves, smoother operations and improved customer experiences across major grocery and supermarket environments.

The company is headquartered in Vancouver, British Columbia.

Products

ShelfieTech offers a comprehensive retail-inventory management platform built around a robotic shelf-monitoring system powered by proprietary software. The system uses machine learning and computer-vision algorithms to capture high-resolution images across shelves, providing precise, real-time insights into product quantity, identification and placement. With scheduled or on-demand scanning, retailers can generate up-to-date shelf data whenever needed.

The company’s technology supports flexible configuration, plug-and-play installation and seamless integration across store environments. Its AI-driven identification engine classifies products, monitors stock levels with accuracy and helps managers optimize both shelf organization and broader capacity planning. The solution enhances retail workflow efficiency by automating the most tedious and error-prone parts of inventory management.

To support in-store teams, ShelfieTech offers a dedicated mobile app for employees, enabling smarter task organization, daily planning and status updates. Managers can access the company’s cloud-based dashboard for a remote, real-time overview of store conditions, empowering data-backed decision-making from any location. Additional features include dynamic advertising screens on the scanner and motion-sensing safety technology that pauses device movement when customers are nearby.

Market Opportunity

ShelfieTech addresses critical inefficiencies in traditional retail inventory management. Human-performed inventory counts average only 63% accuracy, contributing to operational inconsistencies and product shortages. Approximately 46% of inventory errors result directly from manual processes, and 25% of consumers respond negatively when items are out of stock — a factor that directly affects sales and customer loyalty.

These operational challenges create strong market demand for automated solutions that ensure real-time shelf visibility and maintain product availability. As retailers seek to streamline workflows, reduce labor burdens and improve inventory reliability, technologies that combine AI, robotics and automated scanning are becoming increasingly important. ShelfieTech’s platform aligns directly with this industry shift by providing precise, continuous shelf monitoring that helps retailers avoid revenue loss tied to stockouts and inefficient processes.

Leadership Team

Bentsur Joseph, Founder, CEO and Chairman, is a serial entrepreneur with a strong track record in building and expanding successful corporations. He previously served as Chairman of Elad Hotels (part of the Tshuva Group, one of Israel’s largest conglomerates) and held a director position at MARLAZ, a public holding company involved in industrial, real estate, communication, and high-tech sectors. Earlier in his career, he was Operations Manager at Comfy Interactive Movies, a leading publicly traded edutainment company.

Alan Rootenberg, CFO & Corporate Secretary, is a CPA, CA with more than 35 years of experience in business development, senior management, accounting, corporate finance and corporate administration. He oversees financial operations, reporting and corporate governance for the company.

ShelfieTech Ltd. (OTCQB: SHLFF), closed Thursday's trading session at $1.19, up 17.8218%, on 1,500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.01/$1.5.

Recent News

• ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) - NetworkNewsBreaks - ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Advancing Robotic System on Heels of Significant Progress
• InvestorNewsBreaks - Why ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Is 'One to Watch'
• ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Expands Real-Time Shelf Visibility Tools to Transform Global Retail Management

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF)

Disseminated on behalf of Canamera Energy Metals Corp., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF).

Disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) provided an exploration update on its Schryburt Lake Rare Earths Project in northwestern Ontario and announced the engagement of Andrew Best as manager of Indigenous relations to support community engagement initiatives. The company said Schryburt Lake exhibits indications of a multi-centre, carbonatite-hosted rare earth element and niobium system, with four priority targets — Blue Jay, Goldfinch, Blackbird and Starling — defined by coincident kilometre-scale thorium radiometric anomalies and three-dimensional magnetic bodies. Canamera said the targets collectively outline the potential for a vertically extensive REE-niobium system and noted its intention to advance the project responsibly while building relationships with local First Nations as it works toward permitting a maiden drill program.

To view the full press release, visit https://ibn.fm/A5lBX

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) is a rare earth and critical metals exploration company focused on developing a diversified portfolio of district-scale opportunities across the Americas. The company targets jurisdictions with supportive regulatory frameworks, strong geological signatures, and increasing strategic relevance as global supply chains seek alternatives to China’s rare earth dominance. Its assets span ionic clay systems in Brazil, carbonatite complexes in the United States and Canada, and underexplored terrains with meaningful geophysical and geochemical indicators.

Guided by a vision to support North American and allied rare earth supply chains, Canamera concentrates on high-conviction targets where early entry, scalable land positions, and efficient exploration can potentially unlock long-term value. The company’s mission is centered on generating discoveries aligned with the accelerating global demand for critical minerals essential to defense, advanced manufacturing, clean energy technology, and next-generation electronics. Through systematic data-driven exploration, Canamera aims to advance projects aligned with growing efforts to diversify rare earth supply across strategic jurisdictions.

The company is headquartered in Edmonton, Alberta.

Projects

Turvolândia – Minas Gerais, Brazil

Canamera holds an option to acquire up to a 100% ownership interest in the Turvolândia Rare Earth Ionic Clay Project, a 29,574-hectare land package located in Minas Gerais, Brazil’s top mining state and a region responsible for over 30% of national mineral output. The project sits within a prolific corridor of REE-rich alkaline rocks associated with the Poços de Caldas Complex, currently being advanced by multiple industry developers.

Turvolândia benefits from year-round road access, established infrastructure, and supportive local communities. The geological setting includes the São Vicente and Pouso Alegre complexes, where heavily weathered horizons host REE-enriched clays and minerals such as monazite and bastnäsite.

Early exploration confirms REE-bearing clays, with upcoming work focused on property-wide soil sampling and deeper drilling to test the primary ionic clay enrichment horizon and depth potential.

São Sepé – Rio Grande do Sul, Brazil

Canamera also holds an option to acquire up to a 100% interest in the São Sepé Project, which comprises 7,966 hectares in a province known for significant mining activity, including coal, gems, and titanium, and offers strong infrastructure and accessibility. The geology is dominated by an 11-km Rapakivi granite body and advanced-weathered granitoid rocks prospective for potential ionic clay REE mineralization.

While currently undrilled, initial soil sampling indicates the presence of REE enrichment potential. Three priority targets—Erica, Sara, and Maya—have been identified, with planned work including systematic soil sampling and drilling across defined zones. The project also covers a notable uranium-potassium-thorium anomaly, further supporting its rare earth potential.

Iron Hills – Colorado, USA

The Iron Hills Project consists of 85 unpatented lode claims totaling 1,756 acres, held at 100% ownership and located within the Iron Hills / Powderhorn carbonatite complex, one of the premier carbonatite-alkaline systems in the United States. Adjacent to Teck Resources’ Iron Hill deposit, host to one of the country’s largest rare earth oxide and titanium deposits, the project spans two non-contiguous claim blocks positioned along mapped intrusive contacts, felsite porphyry boundaries, and carbonatite dike projections.

Canamera staked these claims in 2025 as part of its U.S. expansion strategy supported by Rangefront Mining Services, and they are pending approval by the BLM.

Schryburt Lake – Ontario, Canada

Through a Joint Venture Option Agreement, Canamera may earn up to a 90% interest in the Schryburt Lake Project, a multi-center carbonatite-hosted REE–Nb system defined by four priority targets: Blue Jay, Goldfinch, Blackbird, and Starling.

These prospects exhibit coincident thorium radiometric highs, coherent magnetic bodies, surface anomalies, and historical trenching. Together, they outline the potential for a vertically extensive and multi-center REE–Nb system. Planned work includes a ~1,000-meter heli-supported scout drilling program following permitting and community consultation.

Garrow – Ontario, Canada

The Garrow Project covers 2,182 hectares located 43 km north-northeast of North Bay and is accessible year-round with strong local infrastructure. Canamera holds an option to acquire a 100% interest in the property.

Regional geochemical datasets include 26 samples above 500 ppm REE across Ontario, and three of these high-value anomalies occur within the Garrow Township area, making it a compelling target for early-stage exploration, including property-wide soil sampling and geophysics to delineate initial drill targets.

Market Opportunity

Rare earth elements play a central role in high-growth industries including electric vehicles, wind turbines, robotics, high-performance electronics, defense systems, and medical imaging, underpinning global trends in electrification, automation, and advanced manufacturing. Their application in permanent magnets, optics and lasers, catalysts, and nuclear and medical technologies positions them as foundational materials for both industrial innovation and national security.

Global demand for rare earth elements is projected to triple—from 59,000 tonnes in 2022 to 176,000 tonnes by 2035—driven by rapid EV adoption and wind-power expansion, with supply expected to lag by up to 30%, according to McKinsey & Company. The global REE market, valued at $3.95 billion in 2024, is forecast to reach $6.3 billion by 2030 at a compound annual growth rate of approximately 8.6%, according to Grand View Research, reflecting a sustained and widening supply-demand imbalance that supports new project development.

China currently controls approximately 60% of global rare earth mining and about 90% of processing capacity, reinforcing persistent price volatility and supply-chain concentration that have been highlighted by historical export restrictions, environmental crackdowns, and geopolitical disruptions. In response, North American governments have accelerated initiatives to strengthen domestic critical-minerals supply chains, including $1 billion in U.S. Department of Energy funding opportunities and Canada’s C$1.5 billion Critical Minerals Infrastructure Fund. Together, these structural shortages, policy tailwinds, and long-term electrification trends underscore the strategic relevance of Canamera’s diversified rare earth portfolio across Brazil, the United States, and Canada.

Leadership Team

Brad Brodeur, CEO & Director, brings more than 27 years of capital markets experience focused on venture-stage issuers, having led over $100 million in financings for junior and start-up companies following senior advisory roles at Raymond James, Canaccord Genuity, and Edward Jones.

Warren Robb, VP Exploration, brings over 35 years of global mineral exploration experience across North America, China, Africa, and South America, including senior roles with Nexus Gold, WPC Resources (now Bluestar Gold), Roxgold, TTM Resources, Majestic Gold, and Trivalence Mining.

Jelena Veljovic, CFO, brings public-company financial reporting and accounting expertise through her work with Treewalk Consulting in Vancouver, supported by prior experience in taxation and private-company accounting at Focus LLP in Calgary.

All technical and scientific information disclosed herein was reviewed and approved by Warren Robb, P.Geo (British Columbia), Vice-President, Exploration, of the Company and a “Qualified Person” as defined by National Instrument 43-101.

For a discussion of the Company’s QA/QC and data verification processes and procedures, please see its most recently filed technical report, a copy of which is available under Canamera’s profile at www.sedarplus.ca.

Canamera Energy Metals Corp. (OTCQB: EMETF), closed Thursday's trading session at $0.77, up 1.6904%, on 290,923 volume. The average volume for the last 3 months is 1,538,290 and the stock's 52-week low/high is $0.279/$0.9.

Recent News

• Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) - RockBreaks - Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Provides Schryburt Lake Exploration Update and Appoints Indigenous Relations Manager
• RockBreaks - Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Provides Schryburt Lake Exploration Update and Appoints Indigenous Relations Manager
• MiningNewsBreaks - Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Provides Schryburt Lake Exploration Update and Appoints Indigenous Relations Manager

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF)

The QualityStocks Daily Newsletter would like to spotlight SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF).

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

Target acquisition is evolving from passive detection toward real-time coordinate generation at the edge

The shift reduces latency and enables autonomous decision-making across defense, security, and commercial systems

SPARC AI's software-based approach turns existing sensors into coordinate-producing platforms without new hardware

For decades, sensing technology has been built around detection rather than precision. Cameras see objects, radar identifies movement, and infrared systems register heat signatures. What these systems often lack is immediate spatial context. Detection alone does not answer the most critical operational question: where exactly is the object, right now, in three-dimensional space? As autonomous systems proliferate and decision cycles compress, that limitation has become increasingly costly.

SPARC AI (CSE: SPAI) (OTCQB: SPAIF) was featured in a recent article that discussed its GPS-free navigation and targeting technology that eliminates the need for physical tethers. "On modern battlefields, the solution to one problem has created another. To counter pervasive electronic warfare and signal jamming, both Russian and Ukrainian forces have turned to fiber-optic FPV drones controlled by physical cables instead of radio frequencies. These un-jammable systems have become so widespread that their fiber-optic cables now litter combat zones, creating tangled webs that Ukrainian special operator Khyzhak describes as a dangerous tactical obstacle. Soldiers must now navigate carefully around these threads, unable to distinguish between harmless cables and deliberate booby traps," reads the publication. "SPARC AI offers a different approach entirely. Rather than replacing one physical dependency with another, the company has developed software-only solutions that enable drones and robotic systems to acquire targets and navigate autonomously without GPS, sensors, radar, lidar, or physical tethers. In signal-jammed environments where fiber-optic drones currently dominate, SPARC AI's technology delivers the same jamming resistance without leaving physical evidence behind."

To view the full article, visit https://ibn.fm/WD6yi

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) develops next-generation, GPS-free target acquisition system and autonomous navigation software for drones and edge devices. Its zero-signature technology delivers real-time detection, tracking, and behavioral insights without reliance on radar, lidar, or heavy sensors. The company’s platform transforms unmanned systems into autonomous tools capable of identifying and engaging targets in GPS-denied environments.

The company’s vision is to redefine situational awareness by merging advanced mathematics, AI modeling, and edge computing into a unified intelligence architecture. SPARC AI aims to empower defense, rescue, and commercial organizations to operate safely and effectively in signal-contested environments where traditional navigation systems fail.

Its mission is to build the world’s most trusted geolocation intelligence platform that operates without GPS, enabling seamless interoperability across air, land, and sea devices.

SPARC AI is headquartered in Toronto, Canada.

Technology

SPARC AI’s technology suite delivers precision target acquisition, navigation, and autonomous intelligence in environments where GPS and traditional sensors fail. At its core is the Target Acquisition System, a software-only solution that determines the geolocation of any visible object using camera telemetry data. By removing the need for specialized hardware like lasers, radar, or lidar, the platform reduces weight, power use, and cost. Built on advanced mathematical modeling, it constructs a 3D understanding of terrain and position, achieving GPS-level accuracy in a zero-signature configuration suited for defense, rescue, and commercial operations.

SPARC AI Mobile extends this capability to handheld and field-issued devices, allowing operators to mark and transmit target coordinates directly from smartphones or rugged tablets. Once a target is identified, the device relays the coordinates to a connected drone, which autonomously navigates to the location for reconnaissance or engagement. The mobile system maintains accuracy even in GPS-jammed or degraded environments, turning each device into a connected node within a broader distributed network.

The company’s GPS-Denied Navigation engine enables mission planning and execution without satellite signals. Operators can design flight paths, define perimeters, and simulate routes to identify optimal vantage points and minimize resource use. Counter-surveillance and threat-prediction tools model adversarial visibility, helping users avoid detection and maximize ground coverage. Together, these capabilities form the foundation of SPARC AI’s software architecture, providing the intelligence backbone for its integrated command platform.

Overwatch Target Intelligence

Overwatch unifies all SPARC AI technologies, including its Target Acquisition, Mobile, and Navigation systems, into a single mission-ready platform that fuses detection, classification, tracking, and navigation in real time. It transforms drones and robotic systems into fully autonomous intelligence assets by synchronizing data across connected devices. The platform’s zero-signature design ensures complete operational security, allowing defense and rescue teams to conduct surveillance, reconnaissance, and engagement without GPS or active sensors.

Within Overwatch, the ATLAS Visibility Intelligence Engine enhances mission planning and reconnaissance through 2D and 3D visualization. Users can simulate line-of-sight coverage from any altitude, identify unseen or occluded areas, and optimize routes for surveillance or search and rescue. Operating entirely through software, ATLAS produces high-fidelity visibility data without mapping drones or additional power consumption, providing a lightweight, silent, and sensor-free alternative to lidar-based systems.

The SPARC AI SDK and open API framework extend Overwatch’s interoperability. Developers can embed SPARC AI’s intelligence into third-party systems such as PX4- and ArduPilot-powered drones, the world’s most widely used open-source flight platforms. The SDK provides REST APIs with bindings for Python, C++, and JavaScript and supports hardware including NVIDIA Jetson, Qualcomm Robotics RB5, and Raspberry Pi. Through these integrations, Overwatch serves as the command and intelligence layer of SPARC AI’s ecosystem, linking distributed drones, sensors, and edge devices into a coordinated autonomous network that operates entirely without GPS.

Market Opportunity

SPARC AI operates within the rapidly expanding defense, security, and commercial drone markets projected to exceed $100 billion over the next decade. The company’s software-defined approach addresses the global demand for autonomous systems capable of performing in denied, degraded, intermittent, and limited (DDIL) environments, positioning SPARC AI at the forefront of next-generation geolocation and targeting solutions.

Fortune Business Insights projects the global commercial drone market will reach approximately $65.25 billion by 2032, while Grand View Research estimates the combined drone hardware and services market will grow to $163.6 billion by 2030. With its per-device subscription model and integration across drones and robotic systems, SPARC AI is structured to capture recurring revenue from this accelerating adoption of GPS-denied intelligence technologies.

Leadership Team

Anoosh Manzoori, CEO, brings extensive experience as a technology entrepreneur, investor, and director, having founded, scaled, and exited multiple high-tech companies. He has taken five companies public, served on seven public company boards, and invested in innovations spanning cloud, fintech, biotech, IoT, defense, and AI.

Justin Hanka, Director, is an investment banking professional with 25 years of experience in mergers and acquisitions and capital markets. He has held executive roles at high-growth companies including iSelect.com.au and Helpmechoose, achieving multiple successful exits.

Anthony Haberfield, Director, is an international financial services executive with 30 years of experience across the Asia Pacific region, specializing in strategy, transformation, procurement, and emerging technology.

SPARC AI Inc. (OTCQB: SPAIF), closed Thursday's trading session at $0.63966, up 10.2862%, on 66,232 volume. The average volume for the last 3 months is 83,770 and the stock's 52-week low/high is $0.0715/$1.3.

Recent News

• SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) - AINewsBreaks - SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Showcased for Next-Gen Technology
• From Detection to Precision: How SPARC AI (CSE: SPAI) (OTCQB: SPAIF) Is Advancing Real-Time Target Acquisition
• NetworkNewsBreaks - SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Builds Momentum in Spatial Computing with STRIKE-1 Drones

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

ESGold (CSE: ESAU) (OTCQB: ESAUF) was featured in an article that discussed its positioning after the closing of its non-brokered private placement of follow-through common shares for aggregate gross proceeds of $4,505,000. "This milestone places ESGold in an advantageous position, with the resources to explore such a valuable mining site and a runway that aims to bring the company close to monetization and profitability much sooner than most of its competitors. It places it ahead of the curve, particularly as it works to stamp its position as a leader in its space," reads the article.

"The Montauban property has shown incredible potential from recent exploration activities and initiatives. For the company's comprehensive three-dimensional geological model analysis of the property, it was noted that the property is not just a reclamation or redevelopment story, but rather the nucleus of a potentially much larger gold, silver, and base-metal district, which is a huge discovery for the company . It shows just how much value the property holds and also emphasizes the need to fast-track its further exploration and extraction of value."

To view the full article, visit https://ibn.fm/SfDRK

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

ESGold Corp. (OTCQB: ESAUF), closed Thursday's trading session at $0.52, up 3.1132%, on 133,025 volume. The average volume for the last 3 months is 168,510 and the stock's 52-week low/high is $0.139/$1.1.

Recent News

• ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) - MiningNewsBreaks - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Gains Momentum as Montauban Shows District-Scale Potential
• NetworkNewsBreaks - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Positions Montauban to Capitalize on Rising Gold and Silver Demand
• ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Position Strengthened as Global Gold Prices Soar

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF)

Disseminated on behalf of Nevada Organic Phosphate Inc., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF).

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) , a British Columbia-based organic sedimentary phosphate exploration company, announced it has elected to accelerate the expiry of 13,968,100 outstanding common share purchase warrants issued under financings completed between Feb. 21 and July 22, 2025, which, if fully exercised, could generate up to $773,405 in gross proceeds. The acceleration follows the Company's common shares achieving a daily volume weighted average price of at least $0.12 on the Canadian Stock Exchange for 10 consecutive trading days, triggering an Acceleration Period that advances the warrant expiry to 5:00 p.m. Vancouver time on Nov. 21, 2025, with proceeds intended to support advancement of the Murdock Mountain Project and general working capital.

To view the full press release, visit https://ibn.fm/TePTD

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) is a junior exploration company focused on exploring and advancing an organic sedimentary raw rock phosphate project in northeast Nevada. The company’s business model centers on developing a rare, direct-application phosphate product that aligns with the growing demand for organic agricultural inputs. Its vision is to support the rapidly expanding organic food industry with a clean, reactive, environmentally responsible nutrient source that avoids the contamination issues associated with chemically processed fertilizers.

NOP is advancing the Murdock Mountain Project through disciplined exploration, responsible environmental practices, and strategic planning that positions the company as a future supplier of organic phosphate to key agricultural markets. The company emphasizes transparency, environmental stewardship, and adherence to regulatory standards as it advances its drill program and project development.

By developing a unique phosphate resource in a mining-friendly U.S. jurisdiction with strong infrastructure access, NOP aims to establish itself as a significant participant in the organic fertilizer sector.

The company is headquartered in Vancouver, British Columbia.

The Murdock Mountain Phosphate Project

NOP’s flagship asset is the Murdock Mountain Phosphate Project in Elko County, Nevada, a nearly flat-lying sediment-hosted phosphate system traced historically over 6.6 kilometers and extended through additional applications to more than 30 kilometers. The project’s raw rock phosphate is characterized by high purity, absence of heavy metals, and suitability for direct application without processing, aided by francolite (the most reactive crystallite structure of all P₂O₅ minerals) and oolitic textures that provide optimal surface area for interaction with soil micro-organisms. The product’s purity places it within the rare 5% of global P₂O₅ material pure enough for direct field application.

The Murdock Mountain property spans four Bureau of Land Management (BLM) applications totaling 7,824 acres, with an Exploration Target Mineral Inventory (ETMI) of 10–46 million tonnes in the initial 1,813-acre area and an additional 200–220 million tonnes across three further applications. Historic geologic mapping and recent drilling identify the Upper Phosphatic Zone within the Meade Peak Member as the primary target, with an interval historically ranging from 3.4 to 7.6 meters thick within a 28–40-meter phosphatic sequence.

In 2025, NOP commenced a multi-hole drill program with unrestricted seasonal timing following regulatory updates. Drill holes MM25-1, MM25-2, MM25-3, MM25-4 and MM25-5 all intersected favorable Meade Peak phosphate-bearing stratigraphy precisely where predicted by geological modeling. These intersections ranged from 29.2 to 38 meters (96 to 125 feet), with drilling confirming the interpreted dip and continuity of the target zone. Ongoing step-out drilling continues along the phosphate trend, supported by geological mapping and XRF screening, with assays pending. The project benefits from proximity to Highway SR 30, the hamlet of Montello, and the Southern Pacific rail line, enabling a simple mining concept summarized by: “break it up, dig it up, grind it up, bag it up, and ship it out.”

Market Opportunity

NOP intends to supply organic, direct-application phosphate fertilizer to the rapidly expanding organic food sector in North America. The company cites a $35 billion organic food market, supported by data from the U.S. Department of Agriculture’s Economic Research Service, which estimated an 8.7% annual growth rate between 2021 and 2027.

The shift toward organic and regenerative agriculture is driving demand for reactive, non-acidulated phosphate sources, and NOP notes that American farming practices are increasingly moving toward direct-application phosphate rather than soluble chemical fertilizers. With only 5% of global P₂O₅ pure enough for direct application, the company is targeting a rare, high-value segment of the fertilizer market that does not require competition with conventional chemical fertilizer producers.

Leadership Team

Robin Dow, Chairman & CEO, brings extensive experience as a public venture capital entrepreneur, following prior roles as a retail and institutional broker and researcher at Burns Fry. He has created more than 30 private and public companies across multiple sectors, raised close to $200 million, and built resource operations spanning four continents, 10 countries, four U.S. States, four Canadian provinces, and three Canadian territories.

Eric Szustak, Director, offers over 39 years of financial services, accounting, business development, and marketing experience, supported by senior roles at firms including Midland Walwyn, Merrill Lynch, and BMO Nesbitt Burns. He is the former President and current Chairman of Quinsam Capital Corporation and holds multiple directorships in publicly listed companies.

Garry K. Smith, Director, contributes more than 40 years of exploration management for companies such as Kerr Addison, Teck, Rio Tinto, and Lac Minerals. As a Qualified Person, he specializes in project generation, 43-101 reporting, resource evaluation, geological modeling, and metal ion soil geochemistry, with a strong focus on ethical and environmentally responsible exploration practices.

Paul W. Pitman, P.Geo., Director, is a field hardened veteran with extensive experience in all areas of geological exploration for a number of metals and materials. He has over 55 years’ experience as an exploration geologist. Since 1983, he has acted as a geological consultant to over 70 clients, providing a full range of services (geological, corporate, and administrative). He has served as a Director or Officer (VP or President) of several junior resource companies, including Boreal Agrominerals, a producer off organic fertilizers from igneous rock in Northern Ontario. He is semi-retired but directs his geological expertise as an advisor to several fertilizer companies.

Nevada Organic Phosphate Inc. (OTCQB: NOPFF), closed Thursday's trading session at $0.148, up 5.9413%, on 131,751 volume. The average volume for the last 3 months is 1,008,850 and the stock's 52-week low/high is $0.0334/$0.1947.

Recent News

• Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) - MiningNewsBreaks - Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Accelerates Expiry of 2025 Warrants
• MiningNewsBreaks - Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Confirms Murdock Mountain Heavy Metal Assays Well Below Organic Fertilizer Limits
• MiningNewsBreaks - Nevada Organic Phosphate Inc. CSE: NOP; OTCQB: NOPFF) Reports Strong Final P?O? Assay Results From 2025 Drill Program

GlobalTech Corp. (OTC: GLTK)

The QualityStocks Daily Newsletter would like to spotlight GlobalTech Corp. (OTC: GLTK).

GlobalTech (OTC: GLTK) is entering a new phase of growth after its recent acquisition of 123 Investments Limited, doing business as Moda in Pelle ("MIP"). "The proposed transactions align with the company's strategic approach of expanding AI and data-driven capabilities into global consumer retail, positioning technology as a driver of long-term value creation and operational efficiency," reads a recent article. "Moda in Pelle is a renowned international footwear and accessories brand, famous for its solid retail presence across various markets. For GLTK, the proposed acquisition presents a unique opportunity to embed AI-powered tools directly into real-time retail operations. Some of the capabilities include inventory optimization, demand forecasting, supply chain intelligence, and customer analytics, strategic areas that are very important in global retail."

To view the full article, visit https://ibn.fm/nxCFO

GlobalTech Corp. (OTC: GLTK) is a U.S.-based technology holding company specializing in artificial intelligence (AI), big data, and digital infrastructure. Advancing toward a Nasdaq listing, the company balances internal innovation with strategic acquisitions to accelerate growth and long-term value creation.

GlobalTech’s diversified portfolio spans AI-powered solutions for enterprise productivity, e-commerce, retail, digital lending, compliance, and other high-growth domains. Flagship platforms include ThrivoAI, Cadnz, Baseball Blitz, Talina, ProtoEd, BillCare, Giftio, and EntityScan. The company also holds a majority stake in WorldCall Telecom Ltd., extending its telecommunications presence in Pakistan and supporting infrastructure-led value creation.

To strengthen market reach, GlobalTech continues to evaluate technology-centric acquisitions while also expanding through strategic regional alliances. Its partnership with significant regional players like Omantel anchors growth in the Middle East, a key gateway market. At the same time, the company’s Center of Excellence (CoE) and #GTCTalks knowledge platform position it as a thought leader in emerging technologies.

Supported by a seasoned leadership team and a disciplined execution model, GlobalTech is building sustainable momentum across global AI and big data markets, with the governance, innovation, and agility required to capture outsized opportunities in the digital economy.

GlobalTech Corp. (OTC: GLTK), closed Thursday's trading session at $1.9371, even for the day. The average volume for the last 3 months is 170 and the stock's 52-week low/high is $1.1/$3.4.

Recent News

• GlobalTech Corp. (OTC: GLTK) - TechMediaBreaks - GlobalTech Corp. (GLTK) Aims to Unlock Retail Capabilities with AI-Powered Integration
• Players in the World Cup to Have AI Avatars to Aid Refereeing
• MissionIRNewsBreaks - GlobalTech Corp. (GLTK) Strategically Positioned at the Intersection of Telecom and Blockchain

Fairchild Gold Corp. (TSX.V: FAIR) (OTC: FCHDF)

The QualityStocks Daily Newsletter would like to spotlight Fairchild Gold Corp. (TSX.V: FAIR) (OTC: FCHDF).

Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) and may include paid advertising.

Fairchild Gold's (TSX.V: FAIR) (OTCQB: FCHDF) flagship Nevada Titan project illustrates the structural opportunity emerging in America's copper sector. "Located just 35 kilometers from Las Vegas in the historic Goodsprings Mining District, the project sits within a belt that produced the equivalent of more than $250 million in minerals (in today's dollars) between the late 1800s and mid-1900s. Historical miners focused primarily on zinc and lead, leaving extensive copper mineralization largely untested by modern techniques," reads a recent article. "Recent surface sampling highlights why interest is returning to districts like Goodsprings. Grades reaching as high as 34% at the Copperside Mine area represent some of the strongest surface results reported in Nevada in recent years. Multiple samples exceeded 20% copper, confirming a 1.5-kilometer mineralized corridor containing both high-grade pods and broader system potential. Sample 350436 returned 34.0% copper alongside 1.27 grams per ton gold and 134 grams per ton silver, a signature consistent with a larger intrusive-driven system."

To view the full article, visit https://ibn.fm/ubUqJ

Fairchild Gold Corp. (TSX.V: FAIR) (OTC: FCHDF) is a mineral exploration company focused on acquiring, exploring, and developing high-quality mineral properties in mining-friendly jurisdictions across North America. The company targets projects with historical production, strong multi-metal potential, and clear pathways to discovery through modern geoscience, AI integration, and responsible development practices.

Fairchild’s portfolio is anchored by the Nevada Titan Project, a district-scale, copper-gold system located just outside Las Vegas in the prolific Walker Lane Belt. The company has also entered into an MOU to acquire the advanced-stage Golden Arrow Project in Nevada, subject to completion of a definitive agreement, and it holds 100% ownership of the Fairchild Lake Property in Ontario.

Fairchild’s mission is to build long-term value by identifying overlooked mineralized systems and unlocking their potential using modern exploration methods.

The company is headquartered in Vancouver, British Columbia.

Projects

Nevada Titan Project (Goodsprings District, Nevada)

Nevada Titan is Fairchild’s flagship asset and a district-scale, multi-metal opportunity located just 55 kilometers southwest of Las Vegas. Spanning over 6,150 acres (300+ claims), the project sits within the historically productive Goodsprings Mining District—part of the prolific Walker Lane Belt and Battle Mountain Trend extension. The area hosts numerous historic mines, including Copperside, Copper Chief, Azurite, and Fitzhugh Lee, yet remains largely untested by modern drilling.

Surface sampling and geological mapping have confirmed high-grade copper mineralization up to 34.0% Cu, with associated values of gold, silver, molybdenum, and platinum group elements. A 1.5-kilometer copper-gold corridor has been identified, showing pods and lenses of mineralization consistent with a porphyry-skarn-CRD system. Notably, the discovery of a hydrothermal breccia pipe with garnet-bearing skarn textures and elevated molybdenum signals a porphyry-affiliated source at depth.

Ongoing exploration includes drone magnetics, AI-integrated targeting, and induced polarization geophysics. With infrastructure already in place and proximity to Las Vegas contractors, Fairchild is preparing for a 2026 drill campaign focused on unlocking the project’s large-scale copper-gold system.

Golden Arrow Project (Walker Lane Shear Zone, Nevada)

In September 2025, Fairchild signed a Memorandum of Understanding to acquire 100% of the Golden Arrow Project, an advanced-stage gold-silver asset in Nevada’s Walker Lane Trend. The project hosts a historic mineral resource estimate of approximately 347,000 ounces of gold and 5.3 million ounces of silver, including 296,500 ounces of gold and 4.0 million ounces of silver in the measured and indicated categories. According to third-party analysis by mining analyst Ryan D. Long, the total acquisition consideration of $5.0 million equates to approximately $12 per ounce of gold in the ground.

The project’s two main deposits, Gold Coin and Hidden Hill, were historically mined at surface and remain open at depth, supported by over 61,000 meters of past drilling. Modern geophysical work has outlined 34 additional exploration targets, including six classified as high-priority. Hosted in a volcanic complex with both high-grade vein and disseminated mineralization, the system offers strong potential for expansion.

Golden Arrow is situated just 96 kilometers from Kinross’s 28-million-ounce Round Mountain Mine and expands Fairchild’s Nevada footprint by 170% when combined with the Titan Project. The project’s extensive exploration database and near-surface deposits make the acquisition a compelling strategic entry point into a proven district with significant near-term development potential.

Fairchild Lake Property (Savant Lake Greenstone Belt, Ontario)

Fairchild Gold holds 100% ownership of the Fairchild Lake Property, a 2,224-hectare claim package in Ontario’s underexplored Savant Lake greenstone belt. Historical and recent work, including airborne geophysics and soil sampling, has identified anomalous gold values near the Kashaweogama Lake Fault, a major crustal break. The company draws geological comparisons to Red Lake’s LP Fault and views the structural setting as a promising focus for future exploration.

Market Opportunity

Fairchild operates in Tier-1 mining jurisdictions where political stability, established infrastructure, and clear permitting pathways reduce development risk and enhance long-term value. Nevada, in particular, is a top-ranked global destination for mineral exploration and home to some of the world’s most productive gold and copper belts. Fairchild’s flagship project, Nevada Titan, is located in the Walker Lane Belt, a prolific trend responsible for more than 89 million ounces of gold and nearly 1 billion ounces of silver to date.

The company is strongly positioned to benefit from the ongoing historic bull market in gold. In early October 2025, Goldman Sachs raised its December 2026 gold price forecast to $4,900 per ounce, citing strong ETF inflows and sustained central bank demand. A Jefferies analyst has projected gold could reach $6,600 per ounce in the near term, while other major institutions including UBS and Bank of America have also raised their targets amid elevated geopolitical risk, structural reserve diversification, and anticipated U.S. rate cuts. With limited new supply and rising demand from both institutional and retail investors, gold remains a cornerstone of portfolio hedging and upside exposure.

Copper also remains a core strategic focus, with demand expected to double by 2035, driven by electrification, grid modernization, and clean energy buildout, according to S&P Global. The Nevada Titan Project hosts porphyry-style copper-gold mineralization, along with skarn and carbonate replacement features—deposit types that are key global sources of both industrial and precious metals.

Leadership Team

Nikolas Perrault, CFA, Executive Chairman, brings over 35 years of experience in capital markets, securities trading, and strategic advisory roles. He began his career with Canada’s top financial institutions and has since focused on guiding small to mid-cap companies through public listings, M&A, and capital raising. He holds a Chartered Financial Analyst designation and a Bachelor of Commerce.

Luís Martins, President and CEO, brings over 40 years of experience in the exploration and mining sector. He previously served as Director of the Mineral Resources Department at Portugal’s Geological Survey and as Director of Mines and Quarries at the Directorate-General of Energy and Geology. He has coordinated international working groups focused on raw materials and mineral policy and has authored more than 100 scientific publications.

Dr. Sergei Diakov, Chair of the Technical Committee and Senior Advisor, is a globally recognized geologist and former discovery lead at both BHP and AngloGold Ashanti. His track record includes major copper-gold discoveries such as Oyu Tolgoi in Mongolia and Nuevo Chaquiro in Colombia. Dr. Diakov brings decades of senior experience managing exploration teams, overseeing risk across geologic and ESG domains, and executing discovery-driven development strategies.

Adam Cavise, Independent Director, brings over 25 years of capital markets experience and has been directly involved in structuring and closing more than $100 billion in public and private equity offerings, SPACs, and recapitalization transactions. Currently a partner at Revere Securities in New York, he has held senior equity roles at Kingswood, Spartan Capital, and Macquarie, and is well regarded for his deep Wall Street network and leadership in equity capital markets.

Fairchild Gold benefits from a deeply experienced leadership and advisory team with expertise across exploration, capital markets, and corporate development. To view the full team, click here.

Fairchild Gold Corp. (OTC: FCHDF), closed Thursday's trading session at $0.055, even for the day. The average volume for the last 3 months is 232,890 and the stock's 52-week low/high is $0.0306/$1.

Recent News

• Fairchild Gold Corp. (TSX.V: FAIR) (OTC: FCHDF) - InvestorNewsBreaks - Fairchild Gold Corp.'s (TSX.V: FAIR) (OTCQB: FCHDF) Nevada Titan Project Shows High-Grade Copper Potential in Nevada
• From Ghost Mines to Geophysical Clarity: How Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) Is Reframing Nevada Titan's Copper-Gold Potential
• InvestorNewsBreaks - TSXV: FAIR; OTCQB: FCHDF; Frankfurt: Y4Y) Commences Trading on OTCQB Venture Market

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

Researchers at the University of Michigan (U-M) have developed a system that leverages both AI and machine learning to create a digital twin of a patient's brain cancer in order to predict how that patient will respond to different treatments. This tool promises to take personalized cancer care a step higher. The study, whose findings appeared in the journal Cell Metabolism, focused on gliomas. The team sought to establish how to distinguish between patients that are likely to benefit when their diets exclude certain amino acids (proteins) and those who are unlikely to benefit from such dietary changes. Some gliomas starve when these nutrients aren't available in the food that a patient consumes, but some gliomas can "scavenge" for those amino acids from within their surroundings and therefore continue growing. The digital twin of each patient was accurate in pointing out which patients could benefit from metabolic therapies and which ones were unlikely to benefit. These results were confirmed when tests were done on mice, proving that the digital twins could be a valuable tool in determining which individuals stood a chance of benefiting from certain treatments even before such treatments have been administered. The potential of this approach is immense, because it could save valuable time and other resources that could have been expended in treating patients who are unlikely to benefit from a given treatment approach. The method could also find application in a lot of other conditions beyond gliomas or brain cancers in general. Given that many companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are hard at work developing new treatments against brain cancers, the machine learning model could be instrumental in getting any new commercialized treatments to patients whose digital twins indicate that the treatment will be effective in killing the tumor cells. Those unlikely to respond could then be given other treatments, helping patients save time, money and the challenges associated with any attendant treatment side effects.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (https://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Thursday's trading session at $6.25, off by 6.994%, on 37,426 volume. The average volume for the last 3 months is 64,358 and the stock's 52-week low/high is $4.93/$114.

Recent News

• CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - New Digital Twin Predicts Outcomes of Brain Cancer Treatments 
• Penn State to Participate in Researching Potential Treatment for Pediatric Brain Cancer
• Preclinical Study Suggests Combo Therapy Could Treat Glioblastoma